| Trial Identifier: | D419EC00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03837899 |
| Start Date: | March 2019 |
| Primary Completion Date: | February 2023 |
| Study Completion Date: | December 2024 |
| Condition: | Myeloma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| German Translation | |
| English UK Translation | |
| Spanish Translation | |
| Spanish (United States) Translation | |
| French Translation | |
| Italian Translation | |
| Dutch Translation |
| Country | Location |
|---|---|
| DE | K�ln, DE, 50924 |
| ES | Barcelona, ES, 08035 |
| ES | Madrid, ES, 28009 |
| FR | Lille Cedex, FR, 59020 |
| FR | Marseille, FR, 13385 |
| FR | Paris Cedex 05, FR, 75248 |
| GB | Leeds, GB, LS1 3EX |
| GB | London, GB, WC1N 3JH |
| GB | Sutton, GB, SM2 5PT |
| IT | Genova, IT, 16100 |
| IT | Milano, IT, 20133 |
| IT | Rome, IT, 00165 |
| IT | Torino, IT, 10126 |
| NL | Utrecht, NL, 3584 CS |
| US, MA | Boston, MA, US, 02115 |
| US, MD | Baltimore, MD, US, 21231 |
| US, NY | New Hyde Park, NY, US, 11040 |
| US, OK | Oklahoma City, OK, US, 73104 |
| US, SC | Charleston, SC, US, 29425 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company